Virginia Medicaid and tirzepatide
Zepbound for weight loss: yes. Service authorization. BMI over 40, or over 37 with high cholesterol, high blood pressure or type 2 diabetes. Must have failed one non-GLP-1 weight-loss drug or be intolerant to all of them, and the provider attests obesity is disabling and life threatening. Age 18 and older, and KwikPen is tried before the unit dose pen. Mounjaro for weight loss: not confirmed; for type 2 diabetes Virginia Medicaid must cover it. Read from Virginia Department of Medical Assistance Services documents Nov 6, 2026.
In 2025 Virginia Medicaid paid for 39,390 tirzepatide prescriptions (Mounjaro, Zepbound), 17% of its GLP-1 prescriptions and 16th of the 50 states and DC. It reimbursed $36.9 million before rebates, $936 a prescription against $1,032 nationally.
| Brand | Prescriptions | Medicaid paid | Per Rx |
|---|---|---|---|
| Mounjaro | 27,595 | $26.3 million | $954 |
| Zepbound | 11,795 | $10.6 million | $895 |
Virginia plans and prescribing rules
Commonwealth of Virginia state employee health plan. Virginia's state employee health plans require a BMI of 35 or higher, plus prior authorization, for a weight-loss GLP-1 under the criteria announced for the 2026 open enrollment.
Tirzepatide in the states around Virginia
| State | Sell tirzepatide, ship there | Cheapest | Medicaid Rx, 2025 | Medicaid, Zepbound for weight loss |
|---|---|---|---|---|
| Virginia | 17 | $69/moWellmedr | 39,390 | Medicaid Zepbound: Yes |
| Kentucky | 17 | $69/moWellmedr | 66,258 | Medicaid Zepbound: No |
| Maryland | 17 | $69/moWellmedr | 20,355 | Medicaid Zepbound: No |
| North Carolina | 17 | $69/moWellmedr | 84,091 | Medicaid Zepbound: Yes |
| Tennessee | 16 | $69/moWellmedr | 44,570 | Medicaid Zepbound: Yes |
| West Virginia | 16 | $69/moWellmedr | 2,257 | Medicaid Zepbound: No |
| Washington, DC | not ranked | none verified | 6,039 | Medicaid Zepbound: No |



